General MedicationsORALStandard
ARIPIPRAZOLE
ARIPIPRAZOLE
Standard Dose
1MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ARIPIPRAZOLE is listed in Drugs@FDA under application 216351 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ARIPIPRAZOLE Form and strength SOLUTION;ORAL - 1MG/ML Sponsor RUBICON RESEARCH Submission history Latest submission status date: 2025-01-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview ARIPIPRAZOLE is listed in Drugs@FDA under application 216351 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ARIPIPRAZOLE Form and strength SOLUTION;ORAL - 1MG/ML Sponsor RUBICON RESEARCH Submission history Latest submission status date: 2025-01-24 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.